Table 2.

The average percent cell viability and percent tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-6 inhibition of the RAW264.7 cells treated with various concentrations of compounds 1 and 2 as well as dexamethasone with 1 μg/mL of LPS. Data are expressed as mean ± SD (standard deviation) of triplicates for each experiment.

Compounds	Concentration (μM)	Mean % Viability	Mean % TNF-α Inhibition	Mean % IL-1β Inhibition	Mean % IL-6 Inhibition
	10	96.9 ± 2.6	22.6 ± 1.6	28.6 ± 1.9	23.8 ± 2.1
1	20	94.8 ± 4.3	28.9 ± 2.7	45.3 ± 3.1	54.4 ± 2.9
	30	95.0 ± 3.7	51.3 ± 4.9	55.9 ± 3.9	78.6 ± 5.0
	10	97.4 ± 2.8	18.7 ± 1.3	12.5 ± 0.8	18.1 ± 1.2
2	20	95.2 ± 5.6	28.2 ± 3.1	23.6 ± 2.5	37.0 ± 3.2
	30	96.0 ± 3.8	51.1 ± 4.7	43.3 ± 2.6	85.4 ± 5.3
	10	95.8 ± 2.9	58.3 ± 4.2	62.1 ± 4.3	58.7 ± 2.3
Dexamethasone	20	101.2 ± 3.6	72.4 ± 3.2	69.7 ± 5.8	82.9 ± 4.7
	30	97.2 ± 5.8	86.4 ± 6.2	80.4 ± 7.3	91.5 ± 7.9